An ADC's Path to Market-Analysis of Difficulties and Key Points in ADC Process Scale up-Case Studies & Whitepapers-End-to-end CDMO | Porton Pharma Solutions

An Antibody-Drug Conjugate (ADC) is a novel therapeutic agent which can deliver a highly-potent traditional small molecule drug to a specific site or cell within the body.  It is formed when an active drug (the payload) is connected to an antibody using a linker. The complex is referred to as an ADC and it uses the cellular specificity of antibodies to direct the payload and deliver to the active disease site within the cell. This enables ADCs to selectively treat cancer cells, tumor microenviro